Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.19.3.a.u2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Total New Residential Stockholders’ Equity
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Total New Residential Stockholders’ Equity
Balance, beginning at Dec. 31, 2016 $ 3,468,177 $ 0 $ 2,507 $ 2,920,730 $ 210,500 $ 126,363 $ 3,260,100 $ 208,077              
Balance, beginning (in shares) at Dec. 31, 2016     250,773,117                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Dividends declared on common stock (608,557)       (608,557)   (608,557)                
Capital distributions (84,196)             (84,196)              
Issuance stock (in shares)     56,545,787                        
Issuance of common and preferred stock 834,529   $ 566 833,963     834,529                
Option exercise (1,386)     (1,386)     (1,386)                
Purchase of noncontrolling interests in the Buyer (65,860)     9,183     9,183 (75,043)              
Director share grants (in shares)     42,405                        
Director share grants 699   $ 1 698     699                
Comprehensive income (loss)                              
Net income (loss) 1,014,652       957,533   957,533 57,119              
Net unrealized gain (loss) on securities 248,412         248,412 248,412                
Reclassification of net realized (gain) loss on securities into earnings (10,308)         (10,308) (10,308)                
Total comprehensive income 1,252,756           1,195,637 57,119              
Balance, ending at Dec. 31, 2017 4,796,162 0 $ 3,074 3,763,188 559,476 364,467 4,690,205 105,957              
Balance, ending (in shares) at Dec. 31, 2017     307,361,309                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Dividends declared on common stock (692,730)       (692,730)   (692,730)                
Capital distributions (64,559)             (64,559)              
Issuance stock (in shares)     57,991,659                        
Issuance of common and preferred stock $ 982,062   $ 580 981,482     982,062                
Option exercised (in shares) 15,803,216   3,694,228                        
Option exercise     $ 37 (37)                      
Purchase of noncontrolling interests in the Buyer $ 9,316     653     653 8,663              
Other dilution (63)     (63)     (63)                
Director share grants (in shares)     57,233                        
Director share grants 1,020   $ 1 1,019     1,020                
Comprehensive income (loss)                              
Net income (loss) 1,004,531       963,967   963,967 40,564              
Net unrealized gain (loss) on securities (7,397)         (7,397) (7,397)                
Reclassification of net realized (gain) loss on securities into earnings 59,953         59,953 59,953                
Total comprehensive income 1,057,087           1,016,523 40,564              
Balance, ending at Dec. 31, 2018 6,088,295 0 $ 3,692 4,746,242 830,713 417,023 5,997,670 90,625              
Balance, ending (in shares) at Dec. 31, 2018     369,104,429                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Dividends declared on common stock (830,995)       (830,995)   (830,995)                
Dividends declared on preferred stock (13,281)       (13,281)   (13,281)                
Capital distributions $ (54,712)             (54,712)              
Issuance stock (in shares)                   46,000,000          
Issuance of common and preferred stock                 $ 751,393 $ 460 $ 750,933 $ 751,393 $ 423,444 $ 423,444 $ 423,444
Option exercised (in shares) 2,041,222   348,613                        
Option exercise     $ 3 (3)                      
Director share grants (in shares)     67,738                        
Director share grants $ 1,055   $ 1 1,054     1,055                
Comprehensive income (loss)                              
Net income (loss) 605,933       563,296   563,296 42,637              
Net unrealized gain (loss) on securities 445,943         445,943 445,943                
Reclassification of net realized (gain) loss on securities into earnings (180,815)         (180,815) (180,815)                
Total comprehensive income 871,061           828,424 42,637              
Balance, ending at Dec. 31, 2019 $ 7,236,260 $ 423,444 $ 4,156 $ 5,498,226 $ 549,733 $ 682,151 $ 7,157,710 $ 78,550              
Balance, ending (in shares) at Dec. 31, 2019     415,520,780